‘The Odyssey’ Lifts IMAX to a Record July and an All-Time High

Shares of IMAX climbed 4.9% on Monday to just above $50, after touching an all-time high of $50.72 earlier in the session. The rally extends a more than 30% jump since Christopher Nolan’s “The Odyssey” debuted in the U.S. on July 17.

The stock move followed the company’s announcement that July was the highest-grossing month in its 50-year history, with $257 million in global box office revenue. Of that total, $221 million came from “The Odyssey,” which IMAX said became the fastest film ever to pass $200 million in global IMAX receipts. Chief Executive Rich Gelfond called the film “a singular achievement in filmmaking” and said its box office trajectory “continues to defy gravity in a way few films ever have.”

Notably, “The Odyssey” has not yet opened in China, Japan or South Korea, markets that could add to IMAX’s haul. The film was shot entirely on IMAX film, and only 25 U.S. theaters can show it in the IMAX 70mm format, with some screenings sold out weeks in advance. Early demand was so strong that some venues added 2 a.m. and 6 a.m. showings, and tickets for the earliest screenings went on sale a year before release.

Why IMAX’s Record Month Rests on One Film — and Three Untapped Markets

A Record Built on One Title

IMAX’s July numbers show how dependent the company’s results are on event-driven blockbusters. The company attributed $221 million of its $257 million monthly total to “The Odyssey” — roughly 86% of the month’s revenue. That is a demonstration of what a hit can do for the premium-format business, but it also means the record is concentrated in a single release. Gelfond’s own language — “virtually impossible to predict how high it will ultimately soar” — acknowledges that even management sees the run as an outlier rather than a baseline.

Advertisement

China, Japan and South Korea Are the Next Test

The film has yet to open in three of the world’s largest theatrical markets. If “The Odyssey” generates premium-format demand in those countries similar to the U.S., IMAX’s record could extend further. The company has not given specific release dates in its announcement, so the timing of those openings is the clearest catalyst to watch. At the same time, the reliance on future market launches is a reminder that today’s all-time high already reflects strong momentum — not certainty about what comes next.

Scarcity Is Doing Some of the Work

The limited availability of IMAX 70mm screenings — just 25 U.S. theaters — helps explain the sold-out shows and unusual late-night and early-morning screenings. Scarcity drives urgency and supports premium pricing, which benefits IMAX and the theaters that carry the format. But it also caps the immediate revenue ceiling: most IMAX screens showing the film are using other digital formats, and only a small number of venues can deliver the maximum-price experience.

A Wider Box Office That Still Rewards Events

IMAX’s record comes in the same period in which Marvel’s “Spider-Man: Brand New Day” posted the largest domestic opening weekend on record, at $360 million, according to the source article. That suggests audience enthusiasm is alive for big-screen event films even as broader theatrical attendance remains uneven. For IMAX, the strategic question is whether the current wave of event cinema is a lasting shift toward premium formats or a temporary surge tied to two unusually strong releases.

What Investors and Exhibitors Can Take From IMAX’s Record Run

  • Investors: watch for official release timing of “The Odyssey” in China, Japan and South Korea; those markets are the main unconfirmed upside to the current record run.
  • Investors: IMAX’s next quarterly update will show whether the July momentum persists beyond “The Odyssey”; treat the 30% post-debut share-price gain and Monday’s all-time high as already reflecting strong current demand.
  • Exhibitors: the sold-out IMAX 70mm shows at only 25 U.S. venues, including 2 a.m. and 6 a.m. screenings, indicate premium-format demand is outrunning supply — evidence to weigh when planning large-format screen investments.

Risk & Opportunity Assessment

Commercial RiskMediumJuly's $257 million record is heavily concentrated in one film — $221 million from “The Odyssey” — so monthly revenue will normalize once its theatrical run ends.
Competitive RiskMediumCompeting event releases such as “Spider-Man: Brand New Day” are also drawing record audiences, while streaming and home viewing remain alternatives for moviegoers.
Regulatory RiskLowNo regulatory or policy development is connected to this story; box office performance and share-price moves are commercial matters.
Reputation RiskMediumCEO Rich Gelfond’s public language about “defying gravity” and shattering records raises expectations; a sharp slowdown after the film’s remaining market openings could weigh on sentiment.
Technology DisruptionMediumOnly 25 U.S. theaters can show the film in IMAX 70mm, capping the premium-format experience; evolving digital projection and home theater technology could reduce the format’s scarcity advantage over time.
Commercial OpportunityHigh“The Odyssey” has yet to open in China, Japan and South Korea, three major theatrical markets, and is already IMAX’s fastest film past $200 million in global receipts.